BackImmunic Overview
Immunic Inc

Immunic Target Price

Where could IMUX trade next? Consensus target price: $32.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.74

Average Target Price

$32.00151.2% upside

2 analysts in the last 4 months

High: $45 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-17WedbushMartin Fan$45253.2% upsideOpen
2026-05-14Roth CapitalBoobalan Pachaiyappan$1949.1% upsideOpen
2026-04-30H.C. WainwrightMatthew Caufield$2272.7% upsideOpen
2026-04-16Stifel Nicolaus$2.580.4% downsideOpen
2022-10-21Leerink PartnersMarket Perform$560.8% downsideOpen

Immunic (IMUX) FAQ

Immunic (IMUX) currently reports a target price of $32. Use the charts on this page to explore Immunic's target price history and peer comparisons.

Analysts' average 12-month price target for Immunic is $32, about 151.2% upside from the current share price of $12.74. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $32, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immunic, and consider following IMUX for alerts when major investors trade the stock.

Immunic is classified in the Healthcare sector. On target price, it currently shows $32. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMUX with unrelated industries.